Return to study ST000566 main page   Show: (1)HMDB and KEGG pathways   (2)REACTOME pathways containing these metabolites

Select	Metabolite Name	Metabolite Id	Refmet Name	Ret. Index	Quant. m/z	Analysis Display
	4-Hydroxybenzenesulfonic acid	ME167735	4-Hydroxybenzenesulfonic acid	4.1259637	-	Reversed phase NEGATIVE ION MODE
	Carboxytolbutamide	ME167690	Carboxytolbutamide	0.91701376	-	Reversed phase NEGATIVE ION MODE
	Sulfamethizole	ME167695	Sulfamethizole	0.9206566	-	Reversed phase NEGATIVE ION MODE
	Valdecoxib	ME167697	Valdecoxib	0.92117447	-	Reversed phase NEGATIVE ION MODE
	Benzenamine sulfate	ME167813	Benzenamine sulfate	0.84656924	-	Reversed phase POSITIVE ION MODE
	Fexofenadine	ME167922	Fexofenadine	11.096588	-	Reversed phase POSITIVE ION MODE
	Valdecoxib	ME167827	Valdecoxib	0.9257945	-	Reversed phase POSITIVE ION MODE